HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

International Conference on COPD and Lung Diseases - Hybrid Event

September 14-15, 2022 | Hybrid Event

Welcome To COPD 2022

Magnus Group stretches a warm invitation to the dynamic scholars from all over the globe to attend its premier learning and networking event “2nd International Conference on COPD and Lung Diseases (COPD 2022).

This global summit is scheduled to take place as Hybrid Event at Paris, France and Virtually during September 14-15, 2022 and is open for all healthcare professionals with a respiratory interest who work in primary care, family medicine, or in the community. 

Based on the theme of “Breathing in New Approaches and Advances in The Field of COPD and Lung Diseases”, this congress will provide a balanced two-day program on the most crucial factors facing primary care nowadays in low, middle, and high-income nations, with pertinent hot topics from respiratory research, education, novel treatment approaches, diagnostic tools and management in primary care. 

The coronavirus disease 2019 (COVID-19) pandemic has infected millions of individuals throughout the world. Patients infected with the coronavirus that causes severe acute respiratory syndrome 2 (SARS-CoV-2) are at risk of developing acute respiratory failure, which can lead to death. Asthma and COPD affect an estimated 10–20 percent of the global population, hence study into the effects of COVID-19 in these patient populations is vital. Chronic respiratory disorders (mainly asthma and COPD) have been implicated as risk factors for severe COVID-19, as have other comorbidities. Patients with asthma and COPD may have more severe outcomes with viral infections due to prior lung function abnormalities, airway hypersensitivity, and immunological changes. Through the global podium of COPD 2022, we sought to explore whether asthma and COPD were risk factors for COVID-19 severe outcomes?

Academicians, educators, researchers, scientists, healthcare professionals, pulmonologists, respiratory specialists, pharmacists, clinicians, nurses, research scholars, students from medical schools, intellectuals, and professionals who are eager to learn and conduct research in the fields of COPD, Asthma and respiration related fields from the world’s most prominent and prestigious scientists are cordially invited to attend and broaden their horizons. COPD 2022 is expected to attract people from all over the globe due to the abundance of informative plenary sessions, keynote lectures, exhibitions, and technical events such as oral and poster presentations.

We believe that this event will serve as an instructive and motivational opportunity for prospective researchers and young scientists to meet with leading professionals in the field of respiratory illnesses. We anticipate you finding this COPD 2022 Congress to be both enlightening and engaging!

Earlybird Registrations Closes on May 31st 2022

Scientific Sessions

  • Chronic Obstructive Pulmonary Disease
  • Lung Transplantation
  • Pulmonary Rehabilitation
  • Cardio Pulmonary Disorders
  • Lung and COVID-19
  • Neonatal Lung Diseases
  • Respiratory Failure
  • Respiratory Infections
  • Pulmonary Hypertension
  • Pulmonary Physiology
  • Occupational Lung Diseases
  • Lung Cancer
  • Streptococcus Pneumonia
  • Allergies
  • Asthma Management

Speakers

Jordan B Minov, Speaker at Pulmonology Congress 2022

Jordan B Minov

Institute for Occupational Health, North Macedonia
George E Chaux, Speaker at COPD congress 2022

George E Chaux

Cedars Sinai Medical Center, United States
Piotr kusnierczyk, Speaker at COPD congress 2022

Piotr kusnierczyk

Polish Academy of Sciences, Poland
Robyn Palk, Speaker at COPD-2022 Congress

Robyn Palk

Allied Health, New Brunswick Community College, Canada
Tammie Fournier, Speaker at COPD congress 2022

Tammie Fournier

Allied Health, New Brunswick Community College, Canada
Ketevan Jugheli, Speaker at COPD congress 2022

Ketevan Jugheli

Akaki Tsereteli State University, Georgia
Carlos Rivas Echeverria, Speaker at COPD-2022

Carlos Rivas Echeverria

The SLEEPCARE Clinics, United Kingdom
Irine Pkhakadze, Speaker at COPD congress 2022

Irine Pkhakadze

Akaki Tsereteli State University, Georgia
Tatyana Sarycheva, Speaker at COPD-2022

Tatyana Sarycheva

Masaryk University, Czech Republic
Lyudmyla Kuyun, Speaker at  Pulmonology Conference

Lyudmyla Kuyun

Bogomolets National Medical University, Ukraine

Past Conference Information

The “International Conference on COPD and Asthma” (COPD 2021) organized virtually by Magnus Group during September 22-23, 2021 with the theme Exchange questions, answers and best practices in the field of COPD and Asthma  was the latest milestone in the field of COPD, Asthma and respiratory disorders.

COPD 2021 opened with Keynote Presentations which included Allen Fred Fielding from Temple University, USA speaking on The EVALI (Vaping Associated Lung Injury) Epidemic; Ahmed Al-Jumaily from Auckland University of Technology, New Zealand speaking on New trends of pressure oscillation in lung therapy  and Jordan B Minov from Institute for Occupational Health of R. North Macedonia, North Macedonia speaking on COPD and workplace.

Upcoming COPD ConferencesCOPD Conferences 2022 | Pulmonology Conferences | Pulmonology Conferences 2022 | Asthma Conferences | Asthma Conferences 2022

Oral Presentations:

Title: The role of basophils in the pathogenesis of COPD
Sho Shibata, Tokyo Medical and Dental University, Japan
Title: Effect of virtual reality resistance exercise in patients with Chronic Obstructive Pulmonary Disease: A randomized control trial
Po-Ching Huang, National Cheng Kung University, Taiwan
Title: COPD healthcare system
Hamid Mcheick, University of Quebec at Chicoutimi, Canada
Title: Lung cancer and covid-19 pandemic; Where do we stand in precision medicine?
Nazila Bahmaie, Near East University (NEU), Cyprus
Title: Analytics for intelligent healthcare systems
Pooja M R, Vidyavardhaka College of Engineering, India
Title: Reposition of Montelukast either alone or in combination with Levocetirizine against SARS-CoV-2
Dipankar Bhattachayya, Chichuria Institute of Medical Science & Research, India
Title: Role of Parainfluenza virus (PIV) and Human metapneumo virus (HMPV) and their codon choices involved in causing lung infection
Title: Risk of type 2 Diabetes in COPD in North Indian population
Seema Singh, King Georges Medical University, India
Title: Tacrolimus Nebulization as an adjunctive medication for severe acute Asthma; A randomized controlled trial
Hassan Motamed, Ahvaz Jundishapur University of Medical Sciences, Iran
Title: Big data and advanced technologies for managing health: A future perspective
Souravh Bais, SAGE University, India
Title: The effects of lifestyle on allergic diseases
Mohammad Rabbani Khorasgani, University of Isfahan, Iran
Title: Effects of viola tricolor flower hydroethanolic extract on lung inflammation in a mouse model of chronic asthma
Elham Harati, Tehran University of Medical Sciences, Iran
Title: COVID-19 cytokine storm complications in asthmatic patients
Seyyed Shamsadin Athari, Zanjan University of Medical Sciences, Iran
Title: Airway remodeling in patients with chronic obstructive pulmonary disease
Nightingale Syabbalo, Nabanji Medical Centre, Zambia
Title: The management of COPD exacerbation in ED
Nalan Metin Aksu, Hacettepe University, Turkey

Poster Presentations: 

Title: Impacts of COVID-19 infection on patients with COPD and Asthma
Shikhar Tripathi, Anna Medical College & Sir Ganga Ram Hospital, India
Title: Estimating the economic burden associated in the treatment of community acquired pneumonia (CAP) among adults with chronic obstructive pulmonary disease (COPD) in Ireland
Simon Walsh, Health Economist, Pfizer, Ireland
Title: The role of EBUS TBNA (endobronchial ultrasound transbronchial needle aspiration) in the diagnosis of small cell lung carcinoma (SCLC) secreting ectopic ACTH (adrenocorticotropic hormone)
Arben Redjepi, Cyril and Methodius University in Skopje, Republic of North Macedonia
Title: The effect of Viola tricolor L. flower hydro-alcoholic extract on anxiety-like behavior in a mouse model of chronic asthma
Elham Harati, Tehran University of Medical Sciences, Iran
Title: Asthma future studies: New treatment strategies and conflicts
Hassan Motamed, Ahvaz Jundishapur University of Medical Sciences, Iran
Title: Proinflammatory cytokines and immunocompetent cells response during COPD exacerbation
Lyudmyla Kuyun, Bogomolets National Medical University, Kyiv, Ukraine

 
Upcoming COPD ConferencesCOPD Conferences 2022 | Pulmonology Conferences | Pulmonology Conferences 2022 | Asthma Conferences | Asthma Conferences 2022

We thank and appreciate all our speakers and delegates for supporting and encouraging us in putting on the conference and propelling us to new heights of success. It also provided an excellent networking opportunity, laying the groundwork for future research and development efforts.

Conference Schedule

08:00-09:00

Registration

09:00-09:30

Opening Ceremony and Introduction

09:30-10:30

Keynote Session I

10:30-11:00

Refreshment Break

11:00-12:30

Keynote Session II

12:30-13:30

Lunch

13:30-15:00

Break Out Session I

15:00-15:30

Refreshment Break

15:30-18:00

Break Out Session II

09:00-10:30

Keynote Session III

10:30-11:00

Refreshment Break

11:00-12:30

Break Out Session III

12:30-13:30

Lunch

13:30 15:00

Poster Presentations

15:00-15:30

Refreshment Break

15:30-17:30

Break Out Session IV

17:30-18:30

Prize Distribution and Closing Ceremony

Get in Touch Make Inquiry

Please feel free to contact us for any information, all the queries will be answered by the conference secretariat within 24 hrs.

Antispam Code Generate new code

Videos Gallery (Our Past Events)

Testimonials

Watsapp